Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Completed 13Unknown 4Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Neuroblastoma 4

Interventions

Radiotherapy 106Cyclophosphamide 97Cisplatin 75Carboplatin 66Fluorouracil 64Etoposide 61Doxorubicin 60Chemotherapy, Adjuvant 60Vincristine 56Peripheral Blood Stem Cell Transplantation 48Filgrastim 47Paclitaxel 46Gemcitabine 44Cytarabine 41Neoadjuvant Therapy 40Leucovorin 40Docetaxel 35Melphalan 31Oxaliplatin 29Methotrexate 29Ifosfamide 25Gene Expression Profiling 25Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 23Dexamethasone 22Irinotecan 21aldesleukin 20Prednisolone 20Interferon-alpha 20Tamoxifen 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NIH × Isotretinoin × Clear all
NCT00526318 2015-07-16

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
360 enrolled
CNS

Neuroblastoma

NCT00030719 2014-06-24

Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
175 enrolled
CNS

Neuroblastoma

NCT00939965 2013-08-12

Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
75 enrolled
CNS

Neuroblastoma

NCT00410631 2013-08-07

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
642 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡